Target intelligence / Profile preview

Natural killer group 2 member D ligand-expressing immunosuppressive cell

Molecular classification
Immune cell
01

Overview

Natural killer group 2 member D (NKG2D) ligand-expressing immunosuppressive cells are immune cells that express ligands for the NKG2D receptor, a potent activating receptor found on natural killer (NK) cells and certain T cell subsets. The expression of these ligands can have both immunostimulatory and immunosuppressive effects depending on the context and cell type involved. These cells contribute to immunosuppression by downregulating or inhibiting effector functions of NK and T cells through persistent or repeated engagement of NKG2D.

02

Biological functions

Immune suppressionImmune modulationAntigen presentationRegulation of cytotoxic lymphocyte activity
03

Disease associations

CancerAutoimmunityChronic inflammationInfection
04

Safety considerations

Potential for immune-related adverse events due to modulation of NK and T cell activityRisk of exacerbating autoimmune conditions
05

Biomarkers

MICAMICBULBP1ULBP2ULBP3ULBP4ULBP5ULBP6

Beyond the preview

Go deeper on Natural killer group 2 member D ligand-expressing immunosuppressive cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural killer group 2 member D ligand-expressing immunosuppressive cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call